Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

IKTIKT
5 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in INHIBIKASE THERAPEUTICS INC

JPMORGAN CHASE & CO holds 316,574 shares of IKT (INHIBIKASE THERAPEUTICS INC), worth $610,988 as of 2026-Q2. The position was decreased (-3.6% shares).

Current Value

$610,988

Current Shares

316,574

Total Value Change

+$555,259

Total Shares Change

+287,995

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
316,574
-3.6%
$610,9880.0%$2.03
0
2026-Q1
Increased
328,518
+1222.1%
$519,0580.0%$1.91
27
2025-Q4
Decreased
24,849
-75.1%
$50,9410.0%$1.97
0
2025-Q3
Increased
99,874
+249.5%
$161,7960.0%$1.53
25
2025-Q2
New
28,579
-
$55,7290.0%$1.62
32

Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used